This report contains market size and forecasts of Drug Device Combination Products in Global, including the following market information:
Global Drug Device Combination Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug Device Combination Products market was valued at 98810 million in 2021 and is projected to reach US$ 136970 million by 2028, at a CAGR of 4.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug-Eluting Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Device Combination Products include Abbott Laboratories, Terumo, Stryker, Mylan, Medtronic, Allergan,, Boston Scientific, Novartis and Teleflex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Device Combination Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Device Combination Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Device Combination Products Market Segment Percentages, by Type, 2021 (%)
Drug-Eluting Stents
Prefilled Syringes
Wearable Injectors
Insulin Injector Drug
Others
Global Drug Device Combination Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Device Combination Products Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Drug Device Combination Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Device Combination Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Device Combination Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug Device Combination Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Terumo
Stryker
Mylan
Medtronic
Allergan,
Boston Scientific
Novartis
Teleflex
BD
W.L.Core & Associates
Gerresheimer
Schott
Nipro